Japan has launched clinical trials for a synthetic, universally compatible blood substitute, marking a potential breakthrough ...

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

A Senate committee rejected Trump's proposed 40% cut to NIH funding. Philadelphia's medical research community says it means ...

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

Neuralink is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.

A new study reveals that astrocyte-derived GABA, not neuronal activity, plays a central role in PTSD by impairing the brain’s ability to extinguish traumatic memories.

Researchers in gastroenterology and hepatology at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have ...

Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of ...

British patients are to be implanted with Elon Musk’s Neuralink brain chip in an attempt to allow paralysed people to control ...

One laboratory at Vanderbilt Medical Center is a key part in that lengthy scientific process with the Vanderbilt Vaccine ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...